AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $242,368 | -91.8% | 25,038 | -90.8% | 0.00% | -88.9% |
Q1 2023 | $2,970,423 | +438.7% | 271,024 | +112.3% | 0.02% | +500.0% |
Q4 2022 | $551,444 | -60.6% | 127,649 | -31.4% | 0.00% | -62.5% |
Q3 2022 | $1,399,000 | -58.8% | 185,979 | -32.2% | 0.01% | -72.4% |
Q1 2022 | $3,397,000 | +6694.0% | 274,374 | +6955.1% | 0.03% | +2800.0% |
Q1 2021 | $50,000 | +92.3% | 3,889 | +109.5% | 0.00% | – |
Q4 2020 | $26,000 | +271.4% | 1,856 | +317.1% | 0.00% | – |
Q3 2020 | $7,000 | -98.3% | 445 | -98.3% | 0.00% | -100.0% |
Q2 2020 | $418,000 | -16.2% | 25,751 | -25.1% | 0.01% | -46.2% |
Q1 2020 | $499,000 | +644.8% | 34,387 | +939.8% | 0.01% | +1200.0% |
Q4 2019 | $67,000 | +116.1% | 3,307 | -42.7% | 0.00% | 0.0% |
Q3 2019 | $31,000 | +933.3% | 5,772 | +1343.0% | 0.00% | – |
Q2 2019 | $3,000 | -98.4% | 400 | -98.6% | 0.00% | -100.0% |
Q1 2019 | $183,000 | +33.6% | 28,100 | +39.8% | 0.01% | 0.0% |
Q4 2018 | $137,000 | +756.2% | 20,100 | +478.9% | 0.01% | +500.0% |
Q4 2017 | $16,000 | – | 3,472 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |